Skip to main content
. 2019 Jan 7;27(2):460–474. doi: 10.1016/j.jfda.2018.11.008

Fig. 6.

Fig. 6

Single-biomarker performance. The performance of four urinary metabolites, quantified by LC-HCT/MS, as single markers of bladder cancer was evaluated using ROC curve analysis. The AUC for O-phosphoethanolamine was 0.709.